CREDIT SUISSE AG/ - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 38 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2021$43,000
-65.9%
31,974
-51.5%
0.00%
Q2 2021$126,000
+180.0%
65,925
+559.2%
0.00%
Q1 2021$45,000
+18.4%
10,0000.0%0.00%
Q2 2020$38,00010,0000.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
HIGHBRIDGE CAPITAL MANAGEMENT LLC 2,413,487$3,3060.09%
CAPITAL PERFORMANCE ADVISORS LLP 25,974$35,5840.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 133,790$183,2920.01%
MEITAV INVESTMENT HOUSE LTD 244,482$318,8280.01%
Psagot Value Holdings Ltd. / (Israel) 6,000$80.00%
IHT Wealth Management, LLC 26,800$36,7160.00%
Altshuler Shaham Ltd 12,478$17,0950.00%
Smith Salley Wealth Management 12,048$16,5060.00%
Ten Capital Wealth Advisors, LLC 1,000$1,3700.00%
BANK OF AMERICA CORP /DE/ 2,967$4,0650.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders